Goodyear-Smith F
Division of General Practice and Primary Health Care, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
Aust N Z J Public Health. 2001 Aug;25(4):371-5. doi: 10.1111/j.1467-842x.2001.tb00597.x.
Genetic modification involves the insertion of genes from other organisms (within or between species) into host cells to select for desirable qualities. Potential benefits of GM foods include increased nutritional value; reduced allergenicity; pest and disease-resistance; and enhanced processing value. Possible detrimental outcomes include producing foods with novel toxins, allergens or reduced nutritional value, and development of antibiotic resistance or herbicide-resistant weeds. Benefits to individuals or populations need to be weighed against adverse health and environmental risks, and may differ between developing and Westernised countries. Whether testing and monitoring should exceed requirements for conventional foods is under debate. While not necessarily scientifically justifiable, consumer concerns have resulted in Australian and New Zealand requirements to label foods containing GM-produced proteins. Dissatisfied consumer advocacy groups are calling for all foods involving GM technology to be labelled, irrelevant of whether the final product contains novel protein. Goals to improve the quantity, quality and safety of foods are laudable; however, the primary aim of the bio-food industry is financial gain. GM foods may be as safe as conventional foods but public distrust runs high. It is important that discussion is informed by science and that claims of both benefits and risks are evidence-based, to ensure that the process is driven neither by the vested interest of the bio-technical multinational companies on the one hand, nor ill-informed public fears on the other.
基因改造涉及将其他生物(物种内或物种间)的基因插入宿主细胞,以筛选出理想的特性。转基因食品的潜在益处包括营养价值提高;致敏性降低;抗病虫害;以及加工价值提升。可能产生的有害后果包括生产出含有新型毒素、过敏原或营养价值降低的食品,以及产生抗生素抗性或抗除草剂杂草。对个人或群体的益处需要与健康和环境方面的不利风险进行权衡,而且在发展中国家和西方国家可能存在差异。对于转基因食品的检测和监测要求是否应高于传统食品,目前仍在争论中。虽然不一定具有科学依据,但消费者的担忧导致澳大利亚和新西兰要求对含有转基因生产蛋白质的食品进行标签标注。不满的消费者权益保护组织呼吁对所有涉及转基因技术的食品进行标签标注,无论最终产品是否含有新型蛋白质。提高食品数量、质量和安全性的目标值得称赞;然而,生物食品行业的主要目标是经济利益。转基因食品可能与传统食品一样安全,但公众的不信任度很高。重要的是,讨论应以科学为依据,关于益处和风险的说法都要有证据支持,以确保该过程既不会被生物技术跨国公司的既得利益所驱动,也不会被公众的无知恐惧所左右。